Federated Hermes’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-147,465
| Closed | -$13.4M | – | 2095 |
|
|
2023
Q2 | $13.4M | Sell |
147,465
-363,837
| -71% | -$33.1M | 0.03% | 478 |
|
|
2023
Q1 | $33.7M | Buy |
511,302
+75,002
| +17% | +$4.95M | 0.08% | 270 |
|
|
2022
Q4 | $22.6M | Buy |
436,300
+85,197
| +24% | +$4.41M | 0.06% | 352 |
|
|
2022
Q3 | $24M | Buy |
+351,103
| New | +$24M | 0.07% | 336 |
|
|
2021
Q4 | – | Sell |
-3,497
| Closed | -$115K | – | 2203 |
|
|
2021
Q3 | $115K | Sell |
3,497
-233,757
| -99% | -$7.69M | ﹤0.01% | 1753 |
|
|
2021
Q2 | $15M | Buy |
237,254
+184,588
| +350% | +$11.7M | 0.03% | 547 |
|
|
2021
Q1 | $2.26M | Sell |
52,666
-64,564
| -55% | -$2.77M | ﹤0.01% | 1067 |
|
|
2020
Q4 | $6.71M | Buy |
+117,230
| New | +$6.71M | 0.01% | 732 |
|
|
2020
Q1 | – | Sell |
-1,434
| Closed | -$44K | – | 2238 |
|
|
2019
Q4 | $44K | Sell |
1,434
-163,197
| -99% | -$5.01M | ﹤0.01% | 1750 |
|
|
2019
Q3 | $3.97M | Buy |
164,631
+163,217
| +11,543% | +$3.93M | 0.01% | 827 |
|
|
2019
Q2 | $36K | Sell |
1,414
-195
| -12% | -$4.97K | ﹤0.01% | 1720 |
|
|
2019
Q1 | $31K | Sell |
1,609
-146
| -8% | -$2.81K | ﹤0.01% | 1705 |
|
|
2018
Q4 | $23K | Sell |
1,755
-562
| -24% | -$7.37K | ﹤0.01% | 1739 |
|
|
2018
Q3 | $41K | Sell |
2,317
-1,010
| -30% | -$17.9K | ﹤0.01% | 1759 |
|
|
2018
Q2 | $73K | Buy |
3,327
+283
| +9% | +$6.21K | ﹤0.01% | 1639 |
|
|
2018
Q1 | $67K | Buy |
+3,044
| New | +$67K | ﹤0.01% | 1627 |
|